If It Is Not Immunoglobulin E-Mediated Allergy, What Is It?
British Journal of Hospital Medicine · 25.03.2026 · 87 (3)
DOI: 10.31083/bjhm52244 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Hospital Medicine, online erschienen am 25.03.2026. Verfasst von Sarah Louise Johnston und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Immunogenetics, North Bristol NHS Trust, BS10 5NB Bristol, UK. Hauptthemen laut MEDLINE: Immunoglobulin E, Hypersensitivity, Immediate, Hypersensitivity. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The term “allergy” is often used ambiguously, frequently applied to a broad spectrum of immune and non-immune reactions, which can create confusion in clinical practice. Whilst there is some controversy, the term “allergy” is now primarily reserved for describing immunoglobulin E (IgE)-mediated (Type I) hypersensitivity. Accurate diagnosis requires distinguishing Type I reactions from their mimics, especially given the clinical overlap with non-IgE-mediated conditions. This review focuses on Type I hypersensitivity, detailing its immunopathogenesis, clinical features, and diagnostic strategies, with particular emphasis on the role of serum tryptase in confirming mast cell activation. A comprehensive clinical history is crucial to distinguishing IgE-mediated allergy from its mimics, focusing on timing, symptom reproducibility, and the identification of potential triggers. Cofactors like non-steroidal anti-inflammatory drugs, alcohol, and exercise may exacerbate reactions, complicating diagnosis. Prompt intramuscular adrenaline administration is essential in cases of anaphylaxis, while patient education and specialist referral are key to long-term management. The review also examines conditions that may mimic Type I reactions, such as chronic spontaneous urticaria or isolated angioedema. In addition to classical allergy, clinicians must consider conditions such as hereditary angioedema, neuroendocrine tumours, and drug-induced pseudoallergic reactions. Recognising these mimics is vital to prevent misdiagnosis, ensuring patient safety, and avoiding unnecessary allergy labels or suboptimal management. This article provides a structured framework for evaluating suspected allergy, enhancing diagnostic accuracy, and guiding appropriate, patient-centred care across allergy and related clinical disciplines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Immunogenetics, North Bristol NHS Trust, BS10 5NB Bristol, UK.
- Allergy & Severe Asthma Service, St Bartholomew's Hospital, Barts Health NHS Trust, EC1A 7BE London, UK.
Zitieren
APA
Johnston, S. L., & Madrigal-Burgaleta, R. (2026). If It Is Not Immunoglobulin E-Mediated Allergy, What Is It?. British Journal of Hospital Medicine, 87(3). https://doi.org/10.31083/bjhm52244
Vancouver
Johnston SL, Madrigal-Burgaleta R. If It Is Not Immunoglobulin E-Mediated Allergy, What Is It?. British Journal of Hospital Medicine. 2026;87(3). doi:10.31083/bjhm52244
BibTeX
@article{Johnston2026,
author = {Johnston, Sarah Louise and Madrigal-Burgaleta, Ricardo},
title = {If It Is Not Immunoglobulin E-Mediated Allergy, What Is It?},
journal = {British Journal of Hospital Medicine},
year = {2026},
volume = {87},
number = {3},
doi = {10.31083/bjhm52244}
}
EUVIMED